LivaNova PLC Ordinary Shares
LIVNStock
$81.79+82.85%52W
Market Cap$4.42B
P/E61.31x
Div yield—
Beta0.87
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)13.43%
Price vs S&P 500 (4W)-0.69%
VGM Score57.34
Market Capitalization$4.42B
P/E Ratio (Annual)61.31x
Earnings Surprise History
Q1 260.98est. 0.91
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.12
4.12
4.19
4.12
Industry Peers — Electromedical Equipment(32)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
LIVNLivaNova PLC Ordinary Shares | C | C | B | $81.79 |
| MDTMedtronic plc | B | C | C | $83.56 |
| MASIMasimo Corporation | D | D | C | $179.95 |
| ITGRInteger Holdings Corporation | B | C | B | $99.62 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | $76.00 |
| AXGNAxogen, Inc. Common Stock | F | B | B | $39.77 |
| BLFSBioLife Solutions Inc. | F | B | A | $30.26 |
| CNMDCONMED Corporation | A | C | B | $45.01 |
| INMDInMode Ltd. Ordinary Shares | A | D | B | $15.60 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $19.14 |
| ELMDElectromed, Inc. | D | B | A | $42.80 |
About
LivaNova is a UK-based medical-device company specializing in cardiopulmonary and neuromodulation solutions. Its portfolio includes heart-lung machines and oxygenation equipment for cardiac and respiratory support, as well as neuromodulation devices for treatment-resistant epilepsy and depression. The company generates approximately 50% of revenue from the US market, 21% from Europe, and the remainder from other regions.